Technology | Computed Tomography (CT) | February 15, 2017

GSI Xtream brings volume spectral CT technology to Revolution CT

GE Healthcare, GSI Xtream, FDA clearance, spectral CT, Revolution, RSNA 2017

February 15, 2017 — GE Healthcare announced U.S. Food and Drug Administration (FDA) 510(k) clearance of GSI Xtream on Revolution CT (computed tomography). The company also announced the first series of clinical images and first installations at Duke University Medical Center (USA), Robarts Research Institute (Canada) and The First Affiliated Hospital of Dalian Medical University (China).

GSI Xtream on Revolution CT is the first volume spectral CT technology designed to improve small lesion detection, tissue characterization and metal artifact reduction, with a simplified workflow.

From setup to post processing, GE said GSI Xtream is as intuitive as a single energy exam. GSI Assist and Clinical ID help standardize and automate protocol selection with images directly transferred to picture archiving and communication systems (PACS) and/or automated workflow (AW). These improvements, combined with native GSI reconstruction, deliver spectral CT workflow that is twice as fast compared to the Revolution HD.

Spectral CT allows clinicians to go beyond anatomy visualization to tissue characterization, allowing for differentiation between similar HU densities such as cysts and enhancing lesions. With a contrast-to-noise ratio 60 percent higher at 120 kV than single energy CT, monochromatic images improve lesion detection and enhance contrast. Bhavik Patel, M.D., assistant professor of radiology, Duke Medical Center, said “By using GSI, we may be able to characterize a lesion for diagnosis from one exam, which could generate cost savings and add value – both clinically for the patient and economically for the health system.”

GSI Xtream enhances Revolution CT’s platform with wide collimation and 50 cm field-of-view (FOV) to deliver the only volume spectral CT. Enabled by ultrafast kV switching, clinicians can scan more challenging patients and reduce the effects of motion. The Gemstone Clarity detector combined with ASiR-V delivers dose neutral exams for patients of any size.

For more information: www.gehealthcare.com


Related Content

News | Radiology Business

March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Time March 30, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
News | Radiology Imaging

March 23, 2026 — Samsung Medison hsa announced that its U.S. medical imaging businesses, previously operating as ...

Time March 23, 2026
arrow
News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Lung Imaging

March 11, 2026 — Noah Medical has announced the publication of the MATCH 2 study in the international, peer-reviewed ...

Time March 12, 2026
arrow
News | Computed Tomography (CT)

March 5, 2026 — At ECR 2026, Royal Philips introduced Rembra, its next-generation radiology CT system designed for the ...

Time March 09, 2026
arrow
Feature | Artificial Intelligence | Kyle Hardner

Once considered an adjunct brain cancer therapy and a last-resort treatment, noninvasive radiosurgery has evolved ...

Time March 09, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
Subscribe Now